Robotics developer Vicarious Surgical nets BD backing in $1.1B SPAC deal

Medical technology giant Becton Dickinson & Co., billionaire Bill Gates and Khosla Ventures are among investors backing robotics startup Vicarious Surgical Inc.’s merger with...

CeQur raises $115M for wearable insulin delivery device

CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million. Lucerne, Switzerland/Marlborough, Mass.-based CeQur said in a news release that it...

Cardiology robotics platform completes seed round of €4.7M with European Heal Capital

The company will use the funding to develop remote user interaction for structural heart interventions. US-based developer of the Coral interventional robotics platform, Moray Medical,...

Memic Innovative Surgery Closes $96M Series D Financing

Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed. Funding primarily supports the commercialisation of Hominis® surgical robot in the United...

Nucleix Secures $55 Million Funding Led by RA Capital Management and Additional Prominent Life Science Investors to Advance Lung EpiCheck® for Early Detection of...

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 million from a syndicate of leading life science...

LumiraDx to merge with CAHC in $5bn deal

CA Healthcare Acquisition Corp.— a special purpose acquisition company — announced today that it entered a merger agreement with LumiraDx that will take the company public. LumiraDx’s...

UroMems Completes €23 Million Series B Financing

Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial of eAUS in patients suffering from...

Carb-X announces up to $13.8m funding for STIs diagnostic

CARB-X is awarding Novel Microdevices, of Baltimore, up to $3.6 million in non-dilutive funding, and, subject to available funding, up to an additional $10.2 million...

Liquid biopsy device aiming to revolutionise cancer diagnosis

Scottish biotech company, BioCaptiva, has developed a “liquid biopsy” technology device that aims to revolutionise the early diagnosis and monitoring of difficult to detect...

Latest articles